Patent · US Active

Compositions for treating dystroglycanopathy disorders

US10350305B2 · kind B2 · utility

0Cited by
0References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 25, 2017
Grant dateJul 16, 2019
Priority date
Expiry dateAug 25, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/008
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to synthetic polynucleotides encoding fukutin related protein (FKRP). The invention further relates to nucleic acid constructs comprising the synthetic polynucleotides and methods of using these synthetic polynucleotides to treat dystroglycanopathy disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.